Review Open Access Logo

Novel Insights into Genetic Approaches in Glioblastoma Multiforme Therapy

Abdul Rahman I. Ghani 1, 2
Esam Bashir Yahya 3, * ORCID logo
Abdulmutalib Alabeed Allaq 4
Atty Sofea Abdul Khalil 5
  1. Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan 16150, Malaysia
  2. Department of Neurosciences, Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan 16150, Malaysia
  3. School of Industrial Technology, Universiti Sains Malaysia, Penang 11800, Malaysia
  4. Faculty of applied science, Universiti Teknologi MARA, Shah Alam, Malaysia
  5. Hospital Seberang Jaya, Jalan Tun Hussein Onn, Seberang Jaya, Permatang Pauh, 13700, Penang, Malaysia
Correspondence to: Esam Bashir Yahya, School of Industrial Technology, Universiti Sains Malaysia, Penang 11800, Malaysia. ORCID: https://orcid.org/0000-0002-1599-1754. Email: essam912013@gmail.com.
Volume & Issue: Vol. 9 No. 1 (2022) | Page No.: 4851-4864 | DOI: 10.15419/bmrat.v9i1.722
Published: 2022-01-29

Online metrics


Statistics from the website

  • HTML Views: 8665
  • PDF Views: 2181
  • XML Views: 77

Statistics from Dimensions

This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Glioblastoma multiforme is one of the most common and malignant types of central nervous system (CNS) tumors. Despite the great advances in treatment modalities and the variety of therapeutic options, it remains largely incurable with continuously growth incidence, due to the genomic instability of glioblastoma multiforme cells, their heterogeneity, and their resistance to chemo- and radiotherapies. The aggressive behavior of these brain tumors and their sequestered location behind the blood–brain barrier restricts the role of the immune system. Great success has been made recently in glioblastoma multiforme treatment using genetic based approaches to selectively target cancerous cells and restore tumor suppressor gene expression or silence specific oncogenes to prevent their expression. The use of genetic approaches has attracted more interest and research and has revealed their ability to regulate the expression of glioblastoma multiforme oncogenes without changing the genotype and thus avoiding possible genotoxicity. This review delivers an overview of glioblastoma multiforme cell biology, tumorigenesis, and immune surveillance, and discusses recent advances in genetic based therapies of glioblastoma multiforme.

Sorry, we can not display full-text of this article in HTML format for you right now. Please get the article in PDF format instead.

Comments